Detection Rate of <sup>68</sup>Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy

Detection Rate of <sup>68</sup>Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy

Prostate-specific membrane antigen (PSMA) ligand PET/CT enables the localization of tumor lesions in patients with recurrent prostate cancer, but it is unclear whether androgen deprivation therapy (ADT) influences diagnostic accuracy. The aim of this study was to evaluate the effect of ADT on the de...

Full description

Bibliographic Details
Main Authors: Joachim Brumberg, Melanie Beckl, Alexander Dierks, Andreas Schirbel, Markus Krebs, Andreas Buck, Hubert Kübler, Constantin Lapa, Anna Katharina Seitz
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Biomedicines
Subjects:
<sup>68</sup>Ga-PSMA ligand PET/CT
androgen deprivation therapy
detection rate
recurrent prostate cancer
Online Access:https://www.mdpi.com/2227-9059/8/11/511

Similar Items

Similar Items